UnitedHealth Group Incorporated (UNH · NYSE)

UnitedHealth Group beat estimates in all four of its last quarterly reports, most recently reporting Q2 EPS of $6.38 versus $4.94 expected, driving earnings growth of 61.5% year over year on revenue of $112.03B. The company discontinued Medicare Advantage plans covering 390,000 members for 2027 as it prioritizes profitability, and reports Q3 results on October 13 with the medical care ratio a key figure to watch. Despite the earnings strength, the stock has fallen 13.3% over three months to $371.90, leaving it 14.3% below its 52-week high, though it remains 5.5% above its 200-day moving average. Leverage stands at 2.7x debt/EBITDA with $28.59B in cash and quarterly free cash flow of $10.25B.